Novo Nordisk's pricing tactics from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of selling price gouging, mentioning the stark distinction amongst U.S. costs and people in Europe and copyright.This led Novo Nordisk to carry out additional exploration into greater dosages of semaglutide s